1 |
钟有清,林 慧. 海南岛类鼻疽40例患者的临床特征及随访分析[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(2): 187-189.
|
2 |
方 静,方 瑶. 类鼻疽的研究进展及诊疗现状[J]. 微生物与感染,2013, 8(2): 115-118.
|
3 |
Arindam C, Christopher H. Melioidosis: An updated review[J]. Aust J Gen Pract, 2019, 48(5): 327-332.
|
4 |
谭云芳,黄增光,吴多荣,等. 海南地区类鼻疽伯克霍尔德菌的药物敏感性分析[J]. 中国抗生素杂志,2017, 42(5): 401-407.
|
5 |
Gassiep I, Armstrong M, Norton R. Human melioidosis[J]. Clin Microbiol Rev, 2020, 33(2): e00006- e00019.
|
6 |
瞿介明,曹 彬. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J]. 中华结核和呼吸杂志,2016, 39(4): 253-279.
|
7 |
Asti L, Bartsch SM, Umscheid CA, et al. The potential economic value of sputum culture use in patients with community-acquired pneumonia and healthcare-associated pneumonia[J]. Clin Microbiol Infect, 2019, 25(8): 1038.e1-1038.
|
8 |
Vidyalakshmi K, Lipika S, Vishal S, et al. Emering clinicoepidemiological trends in melioidosis: analysis of 95 cases from western coastal India[J]. Int J lnfect Dis, 2012, 16(7): e491-e497.
|
9 |
陈 净,何昌华,杨召伍,等. 类鼻疽伯克霍尔德菌致重症肺炎并发脓毒症死亡1例[J]. 中华医院感染学杂志,2023, 33(10): 1495-1499.
|
10 |
中国微生物学会医学微生物学与免疫学专业委员会,重庆市微生物学会临床微生物专业委员会.类鼻疽诊断与治疗专家共识[J]. 中华传染病杂志,2022, 40(10): 577-583.
|
11 |
Price EP, Sarovich DS, Mayo M, et al. Within-host evolution of Burkholderia pseudomallei over a Twelve-Year Chronic Carriage Infection[J]. mBio, 2013, 4(4): e00388-13.
|
12 |
吴烨华,战跃福,俞安乐,等. 海南省26例类鼻疽脾脓肿临床特点分析[J]. 中华传染病杂志,2017, 35(1): 27-30.
|
13 |
Burivong W, Wu X, Saenkote W, et al. Thoracic radiologic manifestations of melioidosis[J]. Curr Probl Diagn Radiol, 2012, 41(6): 199-209.
|
14 |
Sullivan RP, Marshall CS, Anstey NM, et al. 2020 review and revision of the 2015 darwin lioidosis treatment guideline; paradigm drift not shift[J]. PLoS Negl Trop Dis, 2020, 14(9): e0008659.
|
15 |
Wiersinga WJ, Virk HS, Torres AG, et al. Melioidosis[J]. Nature Reviews Disease Primers, 2018, 4: 17107.
|
16 |
Bart JC, Mark M, Linda MW, et al. The darwin prospective melioidosis study: A 30-year prospective,observational investigation[J]. Lancet Infect Dis, 2021, 21(12): 1737-1746.
|
17 |
梁 河,蒙光义,钟丽球,等. 头孢哌酮钠舒巴坦钠致凝血功能障碍研究进展[J]. 中国药业,2020, 29(1): 95-96.
|
18 |
张 菁,吕 媛,于凯江,等. 抗菌药物药代动力学/药效学理论临床应用专家共识[J]. 中华结核和呼吸杂志,2018, 41(6): 409-446.
|
19 |
中国药学会医院药学专业委员会,《人血白蛋白临床应用管理中国专家共识》编写组. 人血白蛋白临床应用管理中国专家共识[J]. 中国医院药学杂志,2024, 44(7): 739-751.
|
20 |
Guilhaumou R, Benaboud S, Bennis Y, et al. Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French society of pharmacology and therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d′Anesthésie et Réanimation-SFAR)[J]. Crit Care, 2019, 23(1): 104.
|